MLYS EBITDA Growth
Mineralys Therapeutics Inc · EBITDA Growth
MLYS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-457.27%period ending
MLYS Quarterly EBITDA YoY % (-3155.03% → -457.27%)
Year-over-year change
High-resolution chart · PNG
MLYS ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -457.275% | |
| 6.785% | |
| 34.1501% | |
| 34.4641% | |
| -5.4945% | |
| -33.9556% | |
| -100.9884% | |
| -147.5% | |
| -237.7399% | |
| -149.8414% | |
| -2,703.7634% | |
| -3,155.0336% |